Management of Patients With Glomerulonephritis During the COVID-19 Pandemic: Recommendations From the Canadian Society of Nephrology COVID-19 Rapid Response Team

Canadian Journal of Kidney Health and Disease

Published: November 26, 2020

Sarah M. Moran, Sean Barbour, Christine Dipchand, Jocelyn S. Garland, Michelle Hladunewich, Arenn Jauhal, Joanne E. Kappel, Adeera Levin, Sanjay Pandeya, Heather N. reich, Susan Thanabalasingam, Dorothy Thomas, Jefrrey C. Ma, Chrisitne White.

Kidney programs across Canada face challenges delivering care during the COVID-19 pandemic. Chronic kidney disease (CKD) and preexisting autoimmune diseases may increase the risk of COVID-19-related complications. In addition, physical distancing has impacted the ways in which health care providers deliver care.

To date, international and national nephrology societies have provided few, if any, recommendations for nondialysis care in the setting of the COVID-19 pandemic. In response to this, the Canadian Society of Nephrology/Societe canadienne de nephrology (CSN/SCN) has created recommendations in an effort to provide optimal care to patients with glomerulonephritis (GN) while we ensure the safety of the health care team.

This document provides suggestions on how to provide the best possible care for patients living with GN during the COVID-19 pandemic. Patients with GN have health care needs that differ from those of patients with other forms of kidney disease, including CKD, end-stage kidney disease including transplantation. The care of other patients with kidney disease, including those with less advanced forms of CKD, is outside the scope of this document.

The recommendations outlined in this guidance document represent best practices based on information available at the time of writing on April 24, 2020.

Read more Online | PDF